New malaria vaccine effective in clinical trial

Researchers have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria┬« PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine. For the trial, scientists used malaria parasites provided by Sanaria….

Researchers have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria┬« PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine. For the trial, scientists used malaria parasites provided by Sanaria….